Fagron NV 경쟁사
가격 내역 및 성능
| 과거 주가 | |
|---|---|
| 현재 주가 | €18.58 |
| 52주 최고치 | €20.05 |
| 52주 최저치 | €16.50 |
| 베타 | 0.27 |
| 11개월 변경 | 3.45% |
| 3개월 변경 사항 | -1.80% |
| 1년 변경 사항 | 9.94% |
| 33년 변화 | 25.20% |
| 5년 변화 | 6.60% |
| IPO 이후 변화 | 84.51% |
최근 뉴스 및 업데이트
Recent updates
Risks To Shareholder Returns Are Elevated At These Prices For Fagron NV (EBR:FAGR)
Oct 07
Fagron NV's (EBR:FAGR) CEO Will Probably Find It Hard To See A Huge Raise This Year
May 07The Returns At Fagron (EBR:FAGR) Aren't Growing
Apr 17Is Fagron (EBR:FAGR) A Risky Investment?
Mar 15Earnings Tell The Story For Fagron NV (EBR:FAGR)
Feb 18Fagron (EBR:FAGR) Seems To Use Debt Quite Sensibly
Aug 11Be Wary Of Fagron (EBR:FAGR) And Its Returns On Capital
Jun 10Fagron (EBR:FAGR) Has Announced That It Will Be Increasing Its Dividend To €0.175
May 12An Intrinsic Calculation For Fagron NV (EBR:FAGR) Suggests It's 30% Undervalued
Apr 20Is Fagron (EBR:FAGR) A Risky Investment?
Apr 02Here's Why Fagron (EBR:FAGR) Can Manage Its Debt Responsibly
Oct 14Return Trends At Fagron (EBR:FAGR) Aren't Appealing
Jun 04Fagron (EBR:FAGR) Is Paying Out A Larger Dividend Than Last Year
May 13Is Fagron (EBR:FAGR) Using Too Much Debt?
Apr 13Slowing Rates Of Return At Fagron (EBR:FAGR) Leave Little Room For Excitement
Feb 16Fagron (EBR:FAGR) Has A Pretty Healthy Balance Sheet
Nov 18Fagron (EBR:FAGR) Is Experiencing Growth In Returns On Capital
Sep 25Are Investors Undervaluing Fagron NV (EBR:FAGR) By 45%?
Aug 30Fagron NV (EBR:FAGR) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?
Aug 08Is Fagron (EBR:FAGR) A Risky Investment?
Jun 15Fagron NV (EBR:FAGR) Shares Could Be 49% Below Their Intrinsic Value Estimate
May 29The Returns At Fagron (EBR:FAGR) Aren't Growing
May 03Here's Why Fagron (EBR:FAGR) Can Manage Its Debt Responsibly
Mar 08Is Fagron NV (EBR:FAGR) A Smart Choice For Dividend Investors?
Feb 22The Returns At Fagron (EBR:FAGR) Provide Us With Signs Of What's To Come
Jan 31Is Fagron NV (EBR:FAGR) Popular Amongst Institutions?
Jan 14
How Much Does Fagron's (EBR:FAGR) CEO Make?
Dec 27Are Investors Undervaluing Fagron NV (EBR:FAGR) By 25%?
Dec 14Fagron (EBR:FAGR) Seems To Use Debt Quite Sensibly
Nov 30Should You Be Excited About Fagron NV's (EBR:FAGR) 26% Return On Equity?
Nov 17Is Fagron (EBR:FAGR) Using Too Much Debt?
Aug 23Why Fagron NV (EBR:FAGR) Looks Like A Quality Company
Aug 10Should Fagron (EBR:FAGR) Be Disappointed With Their 64% Profit?
Jul 28Will Fagron (EBR:FAGR) Multiply In Value Going Forward?
Jul 14What Kind Of Shareholder Owns Most Fagron NV (EBR:FAGR) Stock?
Jun 30주주 수익률
| FAGR | BE Healthcare | BE 마켓 | |
|---|---|---|---|
| 7D | -1.7% | -2.1% | -2.0% |
| 1Y | 9.9% | 12.2% | 8.5% |
수익률 대 산업: FAGR underperformed the Belgian Healthcare industry which returned 12.2% over the past year.
수익률 대 시장: FAGR exceeded the Belgian Market which returned 8.5% over the past year.
가격 변동성
| FAGR volatility | |
|---|---|
| FAGR Average Weekly Movement | 2.1% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in BE Market | 6.5% |
| 10% least volatile stocks in BE Market | 2.2% |
안정적인 주가: FAGR has not had significant price volatility in the past 3 months compared to the Belgian market.
시간에 따른 변동성: FAGR's weekly volatility (2%) has been stable over the past year.
회사 소개
| 설립 | 직원 | CEO | 웹사이트 |
|---|---|---|---|
| 1990 | 3,647 | Rafael Padilla | www.fagron.com |
제약 조제 회사인 Fagron NV는 전 세계 병원, 약국, 클리닉 및 환자에게 맞춤형 의약품을 제공합니다. 이 회사는 세 가지 부문으로 운영됩니다: 에센셜, 브랜드, 컴파운딩 서비스입니다. 또한 제약 컴파운딩을 위한 개념, 수단 및 제형도 혁신하고 있습니다.
Fagron NV 기본 사항 요약
| FAGR 기본 통계 | |
|---|---|
| 시가총액 | €1.36b |
| 수익(TTM) | €77.94m |
| 수익(TTM) | €820.76m |
17.4x
P/E 비율1.7x
P/S 비율FAGR 주가가 과대평가되어 있나요?
공정 가치 및 가치 분석 보기수익 및 수익
| FAGR 손익 계산서(TTM) | |
|---|---|
| 수익 | €820.76m |
| 수익 비용 | €458.22m |
| 총 이익 | €362.54m |
| 기타 비용 | €284.61m |
| 수익 | €77.94m |
최근 보고된 수익
Jun 30, 2024
다음 수익 날짜
n/a
| 주당 순이익(EPS) | 1.07 |
| 총 마진 | 44.17% |
| 순이익 마진 | 9.50% |
| 부채/자본 비율 | 69.2% |
FAGR 의 장기적인 성과는 어땠나요?
과거 실적 및 비교 보기